7th January 2022

The SII Anti-Doping Monitor: week ending 6 January 2022

Only two athletes from two countries were involved in anti-doping proceedings this week. The Russian Athletics Federation (RusAF) announced that Natalia Ryabinina (Grigorieva) (Наталья Рябинина (Григорьева)) has been sanctioned with an 18 month ban after reanalysis of a sample taken on 15 February 2015 returned an adverse analytical finding (AAF) for trimetazidine. 

The runner has already served her ban, which ran from 4 December 2019 until 3 June 2021. Her results from 19 February 2015 until 18 August 2016 were annulled. 

RusAF announced that its Decision was ‘Based on the decision of the Disciplinary Anti-Doping Committee of the Russian Anti-Doping Agency RUSADA No. 181/2021 dated July 15, 2021 (No. BB-5239 dated December 23, 2021)’. However, no Decisions were issued by RUSADA on 15 July this year, and Ryabinina’s sanction was not one of five announced by RUSADA on 23 December. 

Searches performed in Russian on RUSADA’s website using her names, and also using the case numbers, returned no results. A search on the Athletics Integrity Unit (AIU) website using her anglicised names returned the same result, and she doesn’t appear to feature on the AIU’s Global List of Ineligible Persons.

The second athlete was Miroslav Vrebac, who was sanctioned with a four year ban from 26 October 2021, the Anti-Doping Agency of Serbia (ADAS) announced, after returning an AAF for four prohibited substances. The Serbian bodybuilder returned an AAF for boldenone, hydrochlorothiazide, stanozolol and trenbolone at the Vojvodina Championships on 25 September.

However, the fact that only two athletes have been sanctioned this week doesn’t mean that there’s been no anti-doping news. The World Anti-Doping Agency (WADA) published its Anti-Doping Rule Violations (ADRV) Report for 2019. A total of 1,914 ADRVs were recorded, 1,537 of which came from adverse analytical findings (AAFs or ‘positive tests’). The remainder came from investigations.

WADA’s 2019 testing figures Report reveals that a total of 278,047 samples were analysed this year, 2,702 (1%) of which resulted in an AAF. However, only 1,537 of these resulted in an ADRV. In conclusion, 0.5% of anti-doping tests in 2019 resulted in an ADRV.

However 2019 figures from India’s national anti-doping agency (NADA India) show that 4.3% of tests resulted in an ADRV. Its Annual Report noted 165 ADRVs from 3,858 tests during the year. These figures will have been included in the WADA figures suggesting that in some countries, the proportion of ADRVs to tests will fall well below 0.5%.

Please continue to send any cases we may have missed or suggestions through to our editor by clicking here. Also, if you’re an athlete, national anti-doping organisation (NADO) or other Results Management Authority and you’d like us to cover a case that you’re involved with, please get in touch!


Natalia Ryabinina (Grigorieva)
Miroslav Vrebac

You may also like...

Pin It on Pinterest

Share This